Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ANRS 139 TRIO: Raltegravir, Etravirine, and Darunavir/r in Multi-Resistant HIV
NCT00460382Phase 2Completed
- Sponsor
- ANRS
- Start
- May 2007
- Primary completion
- Mar 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of raltegravir, etravirine, darunavir in human immunodeficiency virus type 1 infection (HIV-1), sponsored by ANRS. Started May 2007; status: completed.
02
Drugs
raltegraviretravirinedarunavir
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT00460382.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00460382.